Navigation Links
Vivid 3

ProductsVivid 3
Company GE Healthcare
Item Vivid 3
Features 
  • Up to 18 transducers offer an unprecedented range of applications
  • Advanced 3D option for vascular studies.
  • Enhanced OR performance with TEE and intraoperative probes, and critical time-saving features.
  • Stress Echo option reduces exam times by allowing mid-exam protocol changes for shortened data analysis and report generation.
  • New C721 transducer for pediatric and neonatal applications.
  • Higher frame rates, dynamic range and superb color flow sensitivity.
  • Dual focus and multi-focal capabilities in 2D imaging.
  • Increase patient throughput with full raw data DICOM connectivity that shifts post-exam review to an EchoPAC workstation and frees your system for additional scanning.
  • New MPEGvue option lets you compactly save entire patient records including high-quality images onto CDs that can be transferred easily and inexpensively for remote viewing on your PC via e-mail or network communication.
  • Design custom report templates by selecting the format and appearance you need even import your facilitys logo.
  • Automatic Tissue Optimization (ATO) helps you obtain quality images faster by adjusting the image settings automatically, at the touch of a button.
  • Anatomical M-Mode option lets you correct for off-axis orientation when the heart is not shaped or positioned normally.
Description The Vivid 3 system is designed to address customer requests for another level of cardiovascular performance, and offer an even wider range of clinical applications in vascular, pediatrics and the OR. From color flow imaging with super-high frame rates to DICOM connectivity, the new Vivid 3 offers a wealth of technological innovations that enhance image quality, productivity and patient care.
Info GE HealthcareCall GE Healthcare to buy products (US and Canada only; other locations use number below) USACanada1-866-903-4021

Customer Service: 1-800-957-6837

Related medicine products :

1. Vivid 7
2. Vivid 7 Dimension
3. Vivid i Cardiovascular Portable Ultrasound System
4. Vivid i Cardiovascular Ultrasound System
5. Vivid 4
6. Vivid 3 CV Ultrasound System
7. Vivid e
TAG: Vivid
...ents incorporate a layered design unique in the in... to prevent stray electrosurgical burns along the ...re or capacitive coupling; a well-documented patie...ll AEM Instruments provides a neutral return path ...
...ents incorporate a layered design unique in the in... to prevent stray electrosurgical burns along the ...re or capacitive coupling; a well-documented patie...ll AEM Instruments provides a neutral return path ...
...ents incorporate a layered design unique in the in... to prevent stray electrosurgical burns along the ...re or capacitive coupling; a well-documented patie...ll AEM Instruments provides a neutral return path ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Medicine Products:
(Date:11/21/2008)...k together to stop abusive behavior, experts say ,...ehavior that was once dismissed as "kids being kid...ting research shows the negative effects on both t...ls, schools, parents and even kids themselves are ... behavior. , "Bullying shouldn,t be considered...
(Date:11/21/2008)...USNewswire/ -- During a memorial service in the C...remembered Lieutenant Governor Catherine Baker Kno...public service, and a tireless advocate for the pe...an elected lieutenant governor, Catherine was a no...dell. "Her family and her faith were driving force...
(Date:11/21/2008)... future antibiotic resistance from widespread use ...- People with moderate to severe chronic obstructi...the frequency of exacerbations through a regular, .... , The study, published in the first issue fo... and Critical Care Medicine , found that twice-dai...
(Date:11/21/2008)...e-USNewswire/ -- New research at West Virginia Un...ss tobacco product aimed at young adults is catchi...olds, Camel Snus - touted as a socially acceptable...high levels of nicotine. , , "Camel Snus co...s," said Bruce Adkins of the state Division of Tob...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...f people suffering from spine problems is on the r...c and spinal canal stenosis. Herniated disc is mor...spinal canal stenosis is common among// older peop...hrough conventional spine surgeries which required...
...at least once a month can minimise the risk of isc...archers. Around 607 participants developed strok...olving more than 43,005 men aged 39 to 76. Ischemi...hat blocks the blood vessel supplying the brain wi...
...national survey of more than 149,000 Americans inc...of disability showed that 25% of adults with disab...ility, ran a risk of obesity.// Obesity was define...than 32. The study also highlighted that adults wi...
...ermia by following a few tips on dressing well giv...l you've got to stay indoors when the weather is c... you a lot of good.// But it's important to dress ... cold weather. Just putting on a woolly scarf and ...
Other Medicine News:
(Date:11/19/2008)...ewswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and...iary of,Takeda Pharmaceutical Company Limited (TS...Phase 3 MONET1 trial evaluating motesanib (AMG 706...for the first-line treatment of,advanced non-smal...spended,following a planned safety data review of...
(Date:11/19/2008)...oche- , , MONTVALE, N.J., Nov. 19 /PRNewswi...daq: MEMY ) today announced that it has achieved...7/MEM 3454, its lead alpha-7 nicotinic receptor ag...izophrenia (CIAS). The Company has randomized 212...million payment from its partner Roche. Memory Ph...
(Date:11/18/2008)...ces of Influenza survey underscores that mothers n...other and Gold Medalist Kristi Yamaguchi joins ini...e/ -- While 78 percent of mothers in the United St...ife-threatening disease that can strike anyone, on...accinated this season, according to a new survey f...
(Date:11/12/2008)...SNewswire/ -- A new study being,published in this ...he,question, what causes Parkinson,s disease?, On...search into,Parkinson,s disease is what causes the...place. Answering this question has been especially...types of brain cells that produce,dopamine and the...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 1Novadaq to hold first quarter 2008 results conference call and webcast 18133 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 1Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 4Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 1Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 2Study raises questions about prostate cancer therapies targeting IGF 1 18128 1Study raises questions about prostate cancer therapies targeting IGF 1 18128 2
...May 1, 2007 - Avanir,Pharmaceuticals (NASDAQ:AVNR)... of the investigational drug Zenvia(TM),(dextromet...tary,Emotional Expression Disorder (IEED) were pre...an Academy of Neurology (AAN) 59th,Annual Meeting ...llowing posters: -0-, , 1. Poster P01.090: Inv...
... Disease Activity as Measured,by MRI and Relapse ... Inc.,(NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: B...clinical study of Rituxan®,(rituximab) in pati...RRMS) were presented today at the American Academy...an is a therapeutic antibody,that targets and sele...
Other Medicine Technology:Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 2Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 3Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 4Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6